LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2025 MaTOS Breast 2025 MaTOS GU 2025 PRIMO 2025 South Florida GI Cancer Symposium 2025 Winter Cancer Symposium (WCS) 2024 Advances in Oncology Conference 2024 Best of WCLC San Francisco 2024 California Cancer Consortium Conference (CCC) 2024 MaTOS Lungs 2024 MLS Cleveland 2024 MLS Irvine 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PACC Miami 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 Updates in Cancer Therapies 2024 WCS Clear Displaying 1,426 - 1,450 of 2,995 « 1 … 56 57 58 59 60 … 120 » AML and MDS: Current Status and Future Directions By: Brian A. Jonas, MD, PhD, FACP View Video Recent Advances in Acute Leukemias By: Brian A. Jonas, MD, PhD, FACP View PDF Recent Advances in Acute Leukemias By: Brian Jonas, MD View PDF Recent Advances in Acute Leukemias By: Brian Jonas, MD View Video Recent Advances in Acute Leukemias By: Brian Jonas, MD View PDF Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2) By: Brian Primeaux, PharmD, BCOP View PDF Targeted Therapy in Hema Malignancies (CD20, CD30, CD33, BCR/ABL, FLT3, IDH1/2) By: Brian Primeaux, PharmD, BCOP View Video AML- Where Are We Now and Where Are We Going By: Catherine Lai MD, MPH View PDF Acute Myeloid Leukemia By: Catherine Lai, MD View PDF Acute Myeloid Leukemia By: Catherine Lai, MD View Video AML: Where Are We Now and Where Are We Going? By: Catherine Lai, MD, MPH View PDF AML: Where Are We Now and Where Are We Going? By: Catherine Lai, MD, MPH View Video New Developments in CLL By: Eduardo Sotomayor, MD View PDF New Developments in CLL By: Eduardo Sotomayor, MD View Video Update on Therapy Options for Untreated and Relapsed CLL By: Elizabeth Brém, MD View PDF Update on Therapy Options for Untreated and Relapsed CLL By: Elizabeth Brém, MD View Video Acute Lymphoblastic Leukemia Latest Advances By: Gabriel N. Mannis, MD View PDF AML: Current Status and Future Directions By: George Yaghmour, MD View PDF Advance in Treatment of Acute Lymphocyctic Leukemia By: George Yaghmour, MD View PDF Advance in Treatment of Acute Lymphocyctic Leukemia By: George Yaghmour, MD View Video Myelodysplasia: De Novo and Acquired- What To Do? By: Guillermo Garcia-Manero, MD View PDF Myelodysplasia: De Novo and Acquired- What To Do? By: Guillermo Garcia-Manero, MD View Video Acute Myeloid & Lymphoid Leukemias By: Hugo F. Fernandez, MD View PDF De Novo Acute Myeloid Leukemia By: Hugo F. Fernandez, MD View PDF De Novo Acute Myeloid Leukemia By: Hugo F. Fernandez, MD View Video
